Senzime AB (publ)
SEZI
Rank in Stocks
#22215
Senzime AB (publ) is a medical technology firm specializing in the creation and... Senzime AB (publ) is a medical technology firm specializing in the creation and distribution of advanced patient monitoring solutions. These systems are designed to oversee patients undergoing anesthesia across various global markets, including Europe, Oceania, Asia, Canada, and the United States. Among its primary offerings is the TetraGraph, a sophisticated monitor designed to assess and display muscle function in surgical patients administered neuromuscular blocking agents, by stimulating, measuring, and analyzing responses. This system is complemented by the TetraSens electrode array, featuring two proximal stimulating electrodes for precise recording and reference. For data management, TetraConnect serves as a portal, allowing clinicians to conveniently access, view, and export TetraGraph data records in PDF or Excel formats. Furthermore, TetraGraph Device Connectivity facilitates the transfer of data from the TetraGraph Monitor to other patient monitoring systems, while the TetraGraph Philips Interface specifically enables the transmission of critical neuromuscular monitoring parameters—such as TOFC, TOFR, PTC, and TOF bars—to Philips patient monitors, with readings visible on the Philips Intellivue Monitor. Senzime is also actively developing the CliniSenz Analyzer, intended for continuous postoperative patient monitoring within hospital settings. Another innovation in its pipeline is the Onzurf Probe, a sterile, CE-marked single-use device leveraging micro-dialysis technology for continuous sampling from gastrointestinal organs, including the esophagus, stomach, and liver. The company maintains a strategic licensing and connectivity partnership with Masimo. This collaboration focuses on developing and commercializing the TetraGraph Smart Cable Module, designed to integrate seamlessly with Masimo's Root monitoring system and their digital hubs, thereby enabling interaction with hospital clinical information systems and electronic health records. Established in 1999, Senzime AB (publ) operates from its headquarters in Uppsala, Sweden.
Share Price
$0.35913201
Last synced: 2026-11-09
Market Cap
$56.46M
Change (1 day)
6.04%
Change (1 year)
-37.03%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Senzime AB (publ) (SEZI)
Category
Healthcare
Operating Margin for Senzime AB (publ) (SEZI)
Operating Margin as of November 2026 TTM: -96.96%
According to Senzime AB (publ)'s latest financial reports, its current operating margin (TTM) is -96.96%. At the end of 2025 the company had an operating margin of -116.30%.
Operating Margin history for Senzime AB (publ) from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -96.96% | -16.63% |
| 2025 | -116.30% | -45.18% |
| 2024 | -212.14% | -43.29% |
| 2023 | -374.07% | -60.80% |
| 2022 | -954.15% | 24.44% |
| 2021 | -766.77% | 46.51% |
| 2020 | -523.36% | -3.59% |
| 2019 | -542.86% | -34.80% |
| 2018 | -832.64% | -87.92% |
| 2017 | -6,891.53% | 1,092.16% |
| 2016 | -578.07% | -88.39% |
| 2015 | -4,977.80% | 327.76% |
| 2014 | -1,163.68% | 152.54% |
| 2013 | -460.79% | -68.90% |
| 2012 | -1,481.47% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.16% |
US
|
|
| 18.08% | -100.19% |
IE
|
|
| 21.25% | -100.22% |
US
|
|
| 21.05% | -100.22% |
US
|
|
| 28.09% | -100.29% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Senzime AB (publ)'s operating margin
What is Senzime AB (publ)'s operating margin?
Senzime AB (publ)'s operating margin is -96.96%, as of Nov 2026.
What was Senzime AB (publ)'s operating margin in 2025?
In 2025, Senzime AB (publ)'s operating margin was -116.30%, compared with -212.14% in 2024.
How has Senzime AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, Senzime AB (publ)'s operating margin was highest in 2025 (-116.30%) and lowest in 2022 (-954.15%).
How does Senzime AB (publ)'s operating margin compare with similar companies?
Senzime AB (publ)'s operating margin (-96.96%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.